Arnaud M. Didierlaurent

Geneve, GE, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 69 publications

Baseline interferon signaling in monocytes and antibody-mediated innate activation are associated with reactogenicity to mRNA vaccines.

Baseline interferon signaling in monocytes and antibody-mediated innate activation are associated with reactogenicity to mRNA vaccines.

Journal: Science translational medicine

Published: August 26, 2026

Studying Early Life Live-Attenuated influenza virus immune Responses (STELLAR): study protocol for an exploratory observational study of the nasal mucosal and systemic immune response in healthy children given an intranasal live-attenuated influenza vaccine.

Studying Early Life Live-Attenuated influenza virus immune Responses (STELLAR): study protocol for an exploratory observational study of the nasal mucosal and systemic immune response in healthy children given an intranasal live-attenuated influenza vaccine.

Journal: BMJ open

Published: June 25, 2026

Combination adjuvants: clinical value and mechanisms of action.

Combination adjuvants: clinical value and mechanisms of action.

Journal: Current opinion in virology

Published: April 07, 2026

A Phase Ib, Placebo-controlled Randomized Clinical Trial of the Ebolavirus DNA Vaccine Candidate INO-4201 Followed by Electroporation as Booster Vaccination in Healthy, rVSVΔG-ZEBOV-GP-primed Volunteers (Boost-EBOV).

A Phase Ib, Placebo-controlled Randomized Clinical Trial of the Ebolavirus DNA Vaccine Candidate INO-4201 Followed by Electroporation as Booster Vaccination in Healthy, rVSVΔG-ZEBOV-GP-primed Volunteers (Boost-EBOV).

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: December 05, 2025

A phase Ib, placebo-controlled randomized clinical trial of the Ebolavirus DNA vaccine candidate INO-4201 followed by electroporation as booster vaccination in healthy, rVSVΔG-ZEBOV-GP-primed volunteers (Boost-EBOV).

A phase Ib, placebo-controlled randomized clinical trial of the Ebolavirus DNA vaccine candidate INO-4201 followed by electroporation as booster vaccination in healthy, rVSVΔG-ZEBOV-GP-primed volunteers (Boost-EBOV).

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: December 05, 2025

Adjuvanted influenza vaccination increases pre-existing H5N1 cross-reactive antibodies.

Adjuvanted influenza vaccination increases pre-existing H5N1 cross-reactive antibodies.

Journal: Nature communications

Published: July 07, 2025

Ageing with HIV-1: immunological challenges for effective vaccination.

Ageing with HIV-1: immunological challenges for effective vaccination.

Journal: Immunity & ageing : I & A

Published: June 11, 2025

Age-related changes in the immune system and challenges for the development of age-specific vaccines.

Age-related changes in the immune system and challenges for the development of age-specific vaccines.

Journal: Annals of medicine

Published: March 20, 2025

What is the current evidence base for measles vaccination earlier than 9 months of age?: Report from an informal technical consultation of the World Health Organization.

What is the current evidence base for measles vaccination earlier than 9 months of age?: Report from an informal technical consultation of the World Health Organization.

Journal: Vaccine

Published: January 28, 2025

A novel orf virus vector-based COVID-19 booster vaccine shows cross-neutralizing activity in the absence of anti-vector neutralizing immunity.

A novel orf virus vector-based COVID-19 booster vaccine shows cross-neutralizing activity in the absence of anti-vector neutralizing immunity.

Journal: Human vaccines & immunotherapeutics

Published: October 14, 2024

Functional and epigenetic changes in monocytes from adults immunized with an AS01-adjuvanted vaccine.

Functional and epigenetic changes in monocytes from adults immunized with an AS01-adjuvanted vaccine.

Journal: Science translational medicine

Published: July 31, 2024

Features of chronic urticaria after COVID-19 mRNA vaccine over time.

Features of chronic urticaria after COVID-19 mRNA vaccine over time.

Journal: Communications medicine

Published: March 16, 2024

Showing 1-12 of 69

Last Updated: 09/26/2026